REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
65,04 R$
0,00%
(0,00) 1D
14 қаз., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
64,20 R$
High
65,04 R$
Low
64,20 R$
Mkt. cap
80,14 млрд
Avg. vol.
781,00
Volume
136,00
52-wk high
73,13 R$
52-wk low
49,91 R$
Shares outstanding
101,14 млн
No. of employees
15 мың
Open
64,20 R$
High
65,04 R$
Low
64,20 R$
Mkt. cap
80,14 млрд
Avg. vol.
781,00
Volume
136,00
52-wk high
73,13 R$
52-wk low
49,91 R$
Shares outstanding
101,14 млн
No. of employees
15 мың
News stories
From web sources and news partners
MarketBeat
·
42 минут бұрын
2,188 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by B.A. Schrock Wealth Management Inc.
Simply Wall Street
·
2 сағат бұрын
Regeneron (REGN) Stock Looks Below Fair Value On Earnings
ad-hoc-news.de
·
2 сағат бұрын
UBS upgrades Regeneron stock to Buy at USD 978.00 target
Trefis
·
14 сағат бұрын
What Could Send Regeneron Stock Higher?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15,3 мың
Founded1988
HeadquartersTarrytown, Нью-Йорк, Америка Құрама Штаттары
Sector-
Websiteregeneron.com